<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>McKillop</surname>
    <given-names>A.M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Duffy</surname>
    <given-names>N.A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lindsay</surname>
    <given-names>J.R.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Green</surname>
    <given-names>B.D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Patterson</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>O'Harte</surname>
    <given-names>F.P.</given-names>
   </name>
   <etal>et al</etal>.
  </person-group> (
  <year>2009</year>) 
  <article-title>Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation</article-title>. 
  <source>Eur. J. Endocrinol.</source>
  <volume>161</volume>, 
  <fpage>877</fpage>â€“
  <lpage>885</lpage>
  <pub-id pub-id-type="doi">10.1530/EJE-09-0547</pub-id>
  <?supplied-pmid 19755410?>
  <pub-id pub-id-type="pmid">19755410</pub-id>
 </mixed-citation>
</ref>
